This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by De Siervi, A. Articles by Senderowicz, A. Search for Related Content PubMed PubMed Citation Articles by De Siervi, A. Articles by Senderowicz, A.

Transcriptional Activation of p21^waf1/cip1 by Alkylphospholipids

Role of the Mitogen-Activated Protein Kinase Pathway in the Transactivation of the Human p21^waf1/cip1 Promoter by Sp1

¹ Molecular Therapeutics Unit, Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, NIH, Bethesda, Maryland;
² Department of Pharmacology, Duke University Medical Center, Durham, North Carolina; and
³ Institute of Signalling, Developmental Biology and Cancer Research, Centre Antoine Lacassagne, Nice, France

Alkylphospholipids (ALKs) are a novel class of antitumor agents with an unknown mechanism of action. The first ALK tested in the clinic, miltefosine, has been approved recently in Europe for the local treatment of patients with cutaneous metastasis. Perifosine, the only available oral ALK, is being studied currently in human cancer clinical trials. We have shown previously that perifosine induces p21^waf1/cip1 in a p53-independent fashion and that induction of p21^waf1/cip1 is required for the perifosine-induced cell cycle arrest because cell lines lacking p21^waf1/cip1 are refractory to perifosine. In this report, we investigated the mechanism by which perifosine induces p21^waf1/cip1 protein expression. We observed that perifosine induces the accumulation of p21^waf1/cip1 mRNA without affecting p21^waf1/cip1 mRNA stability. Using several p21^waf1/cip1 promoter-driven luciferase reporter plasmids, we observed that perifosine activates the 2.4-kb full-length p21^waf1/cip1 promoter as well as a p21 promoter construct lacking p53-binding sites, suggesting that perifosine activates the p21^waf1/cip1 promoter independent of p53. The minimal p21 promoter region required for perifosine-induced p21 promoter activation contains four consensus Sp1-binding sites. Mutations in each particular Sp1 site block perifosine-induced p21^waf1/cip1 expression. Moreover, we showed that perifosine activates the mitogen-activated protein/extracellular signal-regulated kinase pathway, and this activation promotes the phosphorylation of Sp1 in known mitogen-activated protein kinase residues (threonine 453 and 739), thereby leading to increased Sp1 binding and enhanced p21^waf1/cip1 transcription. These results represent a novel mechanism by which alkylphospholipids modulate transcription, and may contribute to the discovery of new signal transduction pathways crucial for normal and neoplastic cell cycle control.

This article has been cited by other articles:

				M. Rahmani, A. Anderson, J. R. Habibi, T. R. Crabtree, M. Mayo, H. Harada, A. Ferreira-Gonzalez, P. Dent, and S. Grant The BH3-only protein Bim plays a critical role in leukemia cell death triggered by concomitant inhibition of the PI3K/Akt and MEK/ERK1/2 pathways Blood, November 12, 2009; 114(20): 4507 - 4516. [Abstract] [Full Text] [PDF]

				L. Xiao, M. Eto, and M. G. Kazanietz ROCK Mediates Phorbol Ester-induced Apoptosis in Prostate Cancer Cells via p21Cip1 Up-regulation and JNK J. Biol. Chem., October 23, 2009; 284(43): 29365 - 29375. [Abstract] [Full Text] [PDF]

				H. S. Kim and I. K. Lim Phosphorylated Extracellular Signal-regulated Protein Kinases 1 and 2 Phosphorylate Sp1 on Serine 59 and Regulate Cellular Senescence via Transcription of p21Sdi1/Cip1/Waf1 J. Biol. Chem., June 5, 2009; 284(23): 15475 - 15486. [Abstract] [Full Text] [PDF]

				M. YOSHIDA, Y. MATSUI, A. IIZUKA, and Y. IKARASHI G2-Phase Arrest Through p21(WAF1 / Cip1) Induction and cdc2 Repression by Gnidimacrin in Human Hepatoma HLE Cells Anticancer Res, April 1, 2009; 29(4): 1349 - 1354. [Abstract] [Full Text] [PDF]

				B. GIRI, A. GOMES, R. SENGUPTA, S. BANERJEE, J. NAUTIYAL, F. H. SARKAR, and A. P.N. MAJUMDAR Curcumin Synergizes the Growth Inhibitory Properties of Indian Toad (Bufo melanostictus Schneider) Skin-derived Factor (BM-ANF1) in HCT-116 Colon Cancer Cells Anticancer Res, January 1, 2009; 29(1): 395 - 401. [Abstract] [Full Text] [PDF]

				B. H. Choi, C. G. Kim, Y.-S. Bae, Y. Lim, Y. H. Lee, and S. Y. Shin p21Waf1/Cip1 Expression by Curcumin in U-87MG Human Glioma Cells: Role of Early Growth Response-1 Expression Cancer Res., March 1, 2008; 68(5): 1369 - 1377. [Abstract] [Full Text] [PDF]

				S. Papineni, S. Chintharlapalli, and S. Safe Methyl 2-Cyano-3,11-dioxo-18{beta}-olean-1,12-dien-30-oate Is a Peroxisome Proliferator-Activated Receptor-{gamma} Agonist That Induces Receptor-Independent Apoptosis in LNCaP Prostate Cancer Cells Mol. Pharmacol., February 1, 2008; 73(2): 553 - 565. [Abstract] [Full Text] [PDF]

				J. E. O'Brien, T. J. Peterson, M. H. Tong, E.-J. Lee, L. E. Pfaff, S. C. Hewitt, K. S. Korach, J. Weiss, and J. L. Jameson Estrogen-induced Proliferation of Uterine Epithelial Cells Is Independent of Estrogen Receptor {alpha} Binding to Classical Estrogen Response Elements J. Biol. Chem., September 8, 2006; 281(36): 26683 - 26692. [Abstract] [Full Text] [PDF]

				C.-H. Chao, C.-M. Chen, P.-L. Cheng, J.-W. Shih, A.-P. Tsou, and Y.-H. Wu Lee DDX3, a DEAD Box RNA Helicase with Tumor Growth-Suppressive Property and Transcriptional Regulation Activity of the p21waf1/cip1 Promoter, Is a Candidate Tumor Suppressor. Cancer Res., July 1, 2006; 66(13): 6579 - 6588. [Abstract] [Full Text] [PDF]

				L. de la Pena, W. E. Burgan, D. J. Carter, M. G. Hollingshead, M. Satyamitra, K. Camphausen, and P. J. Tofilon Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells. Mol. Cancer Ther., June 1, 2006; 5(6): 1504 - 1510. [Abstract] [Full Text] [PDF]

				M. Nyakern, A. Cappellini, I. Mantovani, and A. M. Martelli Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways. Mol. Cancer Ther., June 1, 2006; 5(6): 1559 - 1570. [Abstract] [Full Text] [PDF]

				T. Hideshima, L. Catley, H. Yasui, K. Ishitsuka, N. Raje, C. Mitsiades, K. Podar, N. C. Munshi, D. Chauhan, P. G. Richardson, et al. Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells Blood, May 15, 2006; 107(10): 4053 - 4062. [Abstract] [Full Text] [PDF]

				A. E. Bilsland, K. Stevenson, S. Atkinson, W. Kolch, and W. N. Keith Transcriptional Repression of Telomerase RNA Gene Expression by c-Jun-NH2-Kinase and Sp1/Sp3 Cancer Res., February 1, 2006; 66(3): 1363 - 1370. [Abstract] [Full Text] [PDF]

				H. Momota, E. Nerio, and E. C. Holland Perifosine Inhibits Multiple Signaling Pathways in Glial Progenitors and Cooperates With Temozolomide to Arrest Cell Proliferation in Gliomas In vivo Cancer Res., August 15, 2005; 65(16): 7429 - 7435. [Abstract] [Full Text] [PDF]

				J.-A. Lee, D.-C. Suh, J.-E. Kang, M.-H. Kim, H. Park, M.-N. Lee, J.-M. Kim, B.-N. Jeon, H.-E. Roh, M.-Y. Yu, et al. Transcriptional Activity of Sp1 Is Regulated by Molecular Interactions between the Zinc Finger DNA Binding Domain and the Inhibitory Domain with Corepressors, and This Interaction Is Modulated by MEK J. Biol. Chem., July 29, 2005; 280(30): 28061 - 28071. [Abstract] [Full Text] [PDF]

				J. Qian, J. Niu, M. Li, P. J. Chiao, and M.-S. Tsao In vitro Modeling of Human Pancreatic Duct Epithelial Cell Transformation Defines Gene Expression Changes Induced by K-ras Oncogenic Activation in Pancreatic Carcinogenesis Cancer Res., June 15, 2005; 65(12): 5045 - 5053. [Abstract] [Full Text] [PDF]

				S. M. Wuerzberger-Davis, P.-Y. Chang, C. Berchtold, and S. Miyamoto Enhanced G2-M Arrest by Nuclear Factor-{kappa}B-Dependent p21waf1/cip1 Induction Mol. Cancer Res., June 1, 2005; 3(6): 345 - 353. [Abstract] [Full Text] [PDF]

				M. F. Aguero, M. M. Facchinetti, Z. Sheleg, and A. M. Senderowicz Phenoxodiol, a Novel Isoflavone, Induces G1 Arrest by Specific Loss in Cyclin-Dependent Kinase 2 Activity by p53-Independent Induction of p21WAF1/CIP1 Cancer Res., April 15, 2005; 65(8): 3364 - 3373. [Abstract] [Full Text] [PDF]

				K. Venkatasubbarao, A. Choudary, and J. W. Freeman Farnesyl Transferase Inhibitor (R115777)-Induced Inhibition of STAT3(Tyr705) Phosphorylation in Human Pancreatic Cancer Cell Lines Require Extracellular Signal-Regulated Kinases Cancer Res., April 1, 2005; 65(7): 2861 - 2871. [Abstract] [Full Text] [PDF]

				M. Rahmani, E. Reese, Y. Dai, C. Bauer, S. G. Payne, P. Dent, S. Spiegel, and S. Grant Coadministration of Histone Deacetylase Inhibitors and Perifosine Synergistically Induces Apoptosis in Human Leukemia Cells through Akt and ERK1/2 Inactivation and the Generation of Ceramide and Reactive Oxygen Species Cancer Res., March 15, 2005; 65(6): 2422 - 2432. [Abstract] [Full Text] [PDF]

				M. M. Facchinetti, A. De Siervi, D. Toskos, and A. M. Senderowicz UCN-01-Induced Cell Cycle Arrest Requires the Transcriptional Induction of p21waf1/cip1 by Activation of Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase/Extracellular Signal-Regulated Kinase Pathway Cancer Res., May 15, 2004; 64(10): 3629 - 3637. [Abstract] [Full Text] [PDF]